Simiao Qiao

1.1k total citations
32 papers, 865 citations indexed

About

Simiao Qiao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Simiao Qiao has authored 32 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Simiao Qiao's work include Immune cells in cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Simiao Qiao is often cited by papers focused on Immune cells in cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Simiao Qiao collaborates with scholars based in China and United States. Simiao Qiao's co-authors include Yue Dai, Zhifeng Wei, Qi Lv, Yumeng Miao, Yufeng Xia, Kai Wang, Yu Tao, Na Cao, Changjun Lv and Mengfan Yue and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Simiao Qiao

31 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simiao Qiao China 16 434 172 123 102 99 32 865
Xiangming Qi China 21 416 1.0× 208 1.2× 108 0.9× 104 1.0× 62 0.6× 50 1.1k
Yongjian Xiong China 16 390 0.9× 108 0.6× 149 1.2× 107 1.0× 95 1.0× 31 819
Qinggao Zhang China 20 404 0.9× 243 1.4× 91 0.7× 73 0.7× 129 1.3× 51 919
Ruizhi Tan China 21 716 1.6× 188 1.1× 133 1.1× 179 1.8× 94 0.9× 73 1.4k
Huimin Bian China 19 509 1.2× 274 1.6× 93 0.8× 112 1.1× 76 0.8× 46 1.2k
Jie-Jen Lee Taiwan 19 364 0.8× 172 1.0× 68 0.6× 135 1.3× 50 0.5× 34 1.1k
Jihong Han China 20 448 1.0× 162 0.9× 102 0.8× 109 1.1× 39 0.4× 41 1.1k
Gaojun Wu China 19 680 1.6× 249 1.4× 89 0.7× 130 1.3× 42 0.4× 64 1.3k
Hongyan Chai China 17 537 1.2× 118 0.7× 200 1.6× 255 2.5× 107 1.1× 48 949
Maowen Hu United States 11 281 0.6× 192 1.1× 149 1.2× 99 1.0× 85 0.9× 13 762

Countries citing papers authored by Simiao Qiao

Since Specialization
Citations

This map shows the geographic impact of Simiao Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simiao Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simiao Qiao more than expected).

Fields of papers citing papers by Simiao Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simiao Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simiao Qiao. The network helps show where Simiao Qiao may publish in the future.

Co-authorship network of co-authors of Simiao Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Simiao Qiao. A scholar is included among the top collaborators of Simiao Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simiao Qiao. Simiao Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Simiao, et al.. (2025). PM2.5 enhances DRP1-mediated mitochondrial fission to induce ferroptosis and exacerbate asthma through the AHR-HSP90-PKM2 pathway. Toxicology and Applied Pharmacology. 505. 117590–117590.
2.
Ding, Zexuan, Xiaozhe Yin, Yiyan Li, et al.. (2025). Single atom engineering for radiotherapy-activated immune agonist prodrugs. Nature Communications. 16(1). 6021–6021. 3 indexed citations
3.
Qiao, Simiao, et al.. (2024). Combination of radiotherapy and Anlotinib enhances benefit from immunotherapy to liver metastasis and abscopal tumor from lung cancer. International Immunopharmacology. 128. 111441–111441. 3 indexed citations
4.
Wu, Xiaoqian, et al.. (2024). Aryl Hydrocarbon Receptor Activation Limits the Fatty Acid Synthesis and Subsequent “miR-193a-3p-HDAC3-FASN” Signals to Alleviate Intestinal Fibrosis. Journal of Agricultural and Food Chemistry. 72(23). 13069–13082. 1 indexed citations
5.
Qiao, Simiao, et al.. (2024). ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis. International Immunopharmacology. 140. 112729–112729. 4 indexed citations
7.
Yu, Zhen, et al.. (2023). Radiotherapy in the preoperative neoadjuvant treatment of locally advanced rectal cancer. Frontiers in Oncology. 13. 1300535–1300535. 4 indexed citations
8.
Yang, Ting, Simiao Qiao, & Xiaoxia Zhu. (2023). High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway. Journal of Cancer Research and Clinical Oncology. 149(15). 14169–14183. 3 indexed citations
10.
Sun, Dandan, Qin Zhang, Yanrong Zhu, et al.. (2022). The neuropeptide cortistatin attenuates Th17 cell response through inhibition of glycolysis via GHSR1. International Immunopharmacology. 108. 108843–108843. 5 indexed citations
11.
Tao, Yu, Simiao Qiao, Changjun Lv, et al.. (2022). Phytoestrogen arctigenin preserves the mucus barrier in inflammatory bowel diseases by inhibiting goblet cell apoptosis via the ERβ/TRIM21/PHB1 pathway. Phytotherapy Research. 36(8). 3248–3264. 15 indexed citations
12.
Qiao, Simiao, et al.. (2021). Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer. Frontiers in Genetics. 12. 673926–673926. 19 indexed citations
13.
Wang, Qin, et al.. (2021). Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Frontiers in Immunology. 12. 648652–648652. 37 indexed citations
14.
Qiao, Simiao, Changjun Lv, Yu Tao, et al.. (2020). Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer. Cancer Letters. 491. 162–179. 54 indexed citations
15.
Miao, Yumeng, Qi Lv, Simiao Qiao, et al.. (2019). Alpinetin improves intestinal barrier homeostasis via regulating AhR/suv39h1/TSC2/mTORC1/autophagy pathway. Toxicology and Applied Pharmacology. 384. 114772–114772. 44 indexed citations
16.
18.
Qiao, Simiao, Qi Lv, Na Cao, et al.. (2018). Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons. Toxicology and Applied Pharmacology. 343. 1–15. 44 indexed citations
19.
Lv, Qi, Can Shi, Simiao Qiao, et al.. (2018). Alpinetin exerts anti-colitis efficacy by activating AhR, regulating miR-302/DNMT-1/CREB signals, and therefore promoting Treg differentiation. Cell Death and Disease. 9(9). 890–890. 85 indexed citations
20.
Lv, Qi, Kai Wang, Simiao Qiao, Yue Dai, & Zhifeng Wei. (2018). Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome. Chinese Journal of Natural Medicines. 16(3). 161–174. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026